Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 2/2015

01-04-2015 | Case Report

Ross river virus infection in a Thuringian traveller returning from south-east Australia

Authors: B. T. Schleenvoigt, M. Baier, S. Hagel, C. Forstner, R. Kötsche, M. W. Pletz

Published in: Infection | Issue 2/2015

Login to get access

Abstract

Ross River virus (RRV) is an arbovirus transmitted by Aedes and Culex mosquitos. It is endemic in Australia, New Zealand and south-east Asia. Clinical manifestation rates in adults range about 20–40 %. Symptoms involve arthralgia, myalgia, lymphadenopathy, fever and rash. Here we report a case of RRV in a Thuringian traveller who visited the urban South-East of Australia.
Literature
1.
Stocks N, Selden S, Cameron S. Ross river virus infection. diagnosis and treatment by general practitioners in South Australia. Aust Fam Physician. 1997;26:710–7.PubMed
2.
Flexman JP, Smith DW, Mackenzie JS, Fraser JR, Bass SP, Hueston L, Lindsay MD, Cunningham AL. A comparison of the diseases caused by Ross River virus and Barmah Forest virus. Med J Aust. 1998;169:159–63.PubMed
3.
Doherty RL, Gorman BM, Whitehead RH, Carley JG. Studies of epidemic polyarthritis: the significance of three group A arboviruses isolated from mosquitoes in Queensland. Australas Ann Med. 1964;13:322–7.PubMed
4.
Jacups SP, Whelan PI, Currie BJ. Ross river virus and barmah forest virus infections: a review of history, ecology, and predictive models, with implications for tropical northern Australia. Vector Borne Zoonotic Dis. 2008;8:283–97.CrossRefPubMed
5.
Wilder-Smith A, Tambyah PA, Hossain I. Ross river virus disease in a traveler to Australia. J Travel Med. 2009;16:420–3.CrossRefPubMed
6.
Nothdurft HD, Loscher T, Proll S, Dobler G, Pfeffer M, Jelinek T. Persistent arthralgias in ross-river-virus disease after travel to the South Pacific. Dtsch Med Wochenschr. 1999;124:759–62.CrossRefPubMed
7.
Tappe D, Schmidt-Chanasit J, Ries A, Ziegler U, Muller A, Stich A. Ross River virus infection in a traveller returning from northern Australia. Med Microbiol Immunol. 2009;198:271–3.CrossRefPubMed
8.
Moi ML, Takasaki T, Tochitani K, Shimizu T, Shinohara K, Tsuchido Y. The first case report of Ross River virus disease in a Japanese patient who returned from Australia. Kansenshogaku Zasshi. 2014;88:155–9.PubMed
9.
Cramer JP, Kastenbauer U, Loscher T, Emmerich P, Schmidt-Chanasit J, Burchard GD, von Sonnenburg F. Polyarthritis in two travellers returning from Australia. J Clin Virol. 2011;52:1–3.CrossRefPubMed
10.
Harley D, Sleigh A, Ritchie S. Ross river virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev. 2001;14:909–32.CrossRefPubMedCentralPubMed
11.
Rulli NE, Suhrbier A, Hueston L, Heise MT, Tupanceska D, Zaid A, Wilmes A, Gilmore K, Lidbury BA, Mahalingam S. Ross River virus: molecular and cellular aspects of disease pathogenesis. Pharmacol Ther. 2005;107:329–42.CrossRefPubMed
Metadata
Title
Ross river virus infection in a Thuringian traveller returning from south-east Australia
Authors
B. T. Schleenvoigt
M. Baier
S. Hagel
C. Forstner
R. Kötsche
M. W. Pletz
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 2/2015
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0695-0

Other articles of this Issue 2/2015

Infection 2/2015 Go to the issue

Case Report

Epidemiology and outcome of systemic infections due to saprochaete capitata: case report and review of the literature

Case Report

Tubercular liver abscess: an uncommon presentation of disseminated tuberculosis

Correspondence

PCR assay for pathogen detection in ventriculostomy-related meningitis in neurosurgery patients: unanswered questions?

Original Paper

In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens

Original Paper

Clinical management of chronic hepatitis B infection: results from a registry at a German tertiary referral center

Brief Report

Characterization of the dengue outbreak in Nuevo Leon state, Mexico, 2010
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits